| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28,7300 | +3,79% | $1,74B | $55,56K | |
SGRY Surgery Partners, Inc. Common Stock | $13,8790 | +2,73% | $1,74B | $154,38K | |
GAB The Gabelli Equity Trust Inc. | $5,6050 | -0,09% | $1,74B | $282,57K | |
HURN Huron Consulting Group Inc. | $108,12 | +3,17% | $1,74B | $10,42K | |
ENVX Enovix Corporation Common Stock | $8,1840 | -0,56% | $1,74B | $1,63M | |
PAYO Payoneer Global Inc. Common Stock | $5,2450 | +3,05% | $1,74B | $582,10K | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,8950 | -0,10% | $1,73B | $35,34K | |
STGW Stagwell Inc. Class A Common Stock | $6,8050 | +3,26% | $1,73B | $92,15K | |
CASH Pathward Financial, Inc. Common Stock | $79,3940 | +2,13% | $1,73B | $14,90K | |
SNDX Syndax Pharmaceuticals, Inc. | $17,8990 | -2,40% | $1,73B | $3,14M | |
STRA Strategic Education, Inc. Common Stock | $81,4100 | +2,99% | $1,73B | $32,43K | |
CAPR Capricor Therapeutics Inc | $28,1850 | +1,97% | $1,73B | $78,31K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18,4590 | +3,30% | $1,73B | $1,56K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,7820 | +7,23% | $1,73B | $1,63M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $28,3110 | +13,29% | $1,73B | $188,10K | |
